A Focus Group Study of Self-Management in Patients With Glomerular Disease
Simon A. Carter,Claris Teng,Talia Gutman,Charlotte Logeman,Dan Cattran,Liz Lightstone,Arvind Bagga,Sean J. Barbour,Jonathan Barratt,John Boletis,Dawn J. Caster,Rosanna Coppo,Fernando C. Fervenza,Jürgen Floege,Michelle A. Hladunewich,Jonathan J. Hogan,A. Richard Kitching,Richard A. Lafayette,Ana Malvar,Jai Radhakrishnan,Brad H. Rovin,Nicole Scholes-Robertson,Hernán Trimarchi,Hong Zhang,Karolis Azukaitis,Yeoungjee Cho,Andrea K. Viecelli,Louese Dunn,David Harris,David W. Johnson,Peter G. Kerr,Paul Laboi,Jessica Ryan,Jenny I. Shen,Lorena Ruiz,Angela Yee-Moon Wang,Achilles Hoi Kan Lee,Samuel Fung Ka Shun,Matthew Ka-Hang Tong,Armando Teixeira-Pinto,Martin Wilkie,Stephen I. Alexander,Jonathan C. Craig,Adam Martin,Allison Tong
DOI: https://doi.org/10.1016/j.ekir.2021.10.011
IF: 6.234
2022-01-01
Kidney International Reports
Abstract:INTRODUCTION: Patients with glomerular disease experience symptoms that impair their physical and mental health while managing their treatments, diet, appointments and monitoring general and specific indicators of health and their illness. We sought to describe the perspectives of patients and their care partners on self-management in glomerular disease.METHODS: We conducted 16 focus groups involving adult patients with glomerular disease (<i>n</i> = 101) and their care partners (<i>n</i> = 34) in Australia, Hong Kong, the United Kingdom, and United States. Transcripts were analyzed thematically.RESULTS: We identified the following 4 themes: empowered in autonomy (gaining confidence through understanding, taking ownership of disease and treatment, learning a positive health approach); overwhelmed by compounding treatment burdens (financially undermined and depleted, demoralized by side effects and harms, frustrated by fragmented and inflexible care, fear of possible drug harms); striving for stability and normalcy (making personal sacrifices, maximizing life participation, attentiveness to bodily signs, avoiding precarious health states, integrating medicines into routines); and necessity of health-sustaining relationships (buoyed by social support, fulfilling meaningful responsibilities, sharing and normalizing experiences, seeking a trusting and respectful alliance).CONCLUSION: Patients with glomerular disease and their care partners value their capacity for autonomy and disease ownership, stability of their health, and relationships that support self-management. Strategies directed at strengthening these factors may increase self-efficacy and improve the care and outcomes for patients with glomerular disease.
urology & nephrology